Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EGFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NSFL1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TROVE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTTY14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TRIM50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ITCH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFDN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FFAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC28B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928894 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR646HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BBIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on